Skip to content

Research at St Andrews

Phenotypic resistance in mycobacteria: is it because I am old or fat that I resist you?

Research output: Research - peer-reviewArticle

DOI

Open Access permissions

Open

Author(s)

Robert J H Hammond, Vincent O Baron, Katarina Oravcova, Sam Lipworth, Stephen H Gillespie

School/Research organisations

Abstract

Synopsis
Objectives
We aimed to explore the phenomenon of phenotypic resistance to anti-mycobacterial antibiotics and to determine whether this was associated with cell age or presence of lipid bodies.

Methods
The accumulation of lipid body positive cells (lipid rich- LR) was followed using cell staining and flow cytometry. LR cells of M. smegmatis, M. marinum, M. fortuitum and BGC were separated from non-lipid body containing cells (lipid poor- LP) and their MBC determined. We also compared the MBC of LR and LP from “old” and “young” cultures.


Results
The LR cells of all species were more resistant to antibiotics than LP cells. For Mycobacterium bovis (BCG) the susceptibility ratios were as follows; Rifampicin-5X, isoniazid-16.7X, ethambutol-5X, ciprofloxacin-5X. Phenotypic resistance was found in LR cells irrespective of cell age.

Conclusions
We have shown that phenotypic antibiotic resistance is associated with the presence of lipid bodies irrespective of cell age. These data have important implications for our understanding of relapse in mycobacterial infections.

Close

Details

Original languageEnglish
JournalJournal of Antimicrobial Chemotherapy
VolumeAdvance Access
DOIs
StatePublished - 9 Jul 2015

    Research areas

  • Mycobacterium tuberculosis, Antibiotic resistance, Lipid rich, Lipid poor

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. The impact of repeated NALC/NaOH- decontamination on the performance of Xpert MTB/RIF assay

    Rachow, A., Saathoff, E., Mtafya, B., Mapamba, D., Mangu, C., Rojas-Ponce, G., Ntinginya, N. E., Boeree, M., Heinrich, N., Gillespie, S. H., Hoelscher, M. & on behalf of the PanACEA-Consortium 4 Apr 2018 In : Tuberculosis. In press

    Research output: Research - peer-reviewArticle

  2. A population pharmacokinetic model incorporating saturable pharmacokinetics and autoinduction for high rifampicin doses

    Svensson, R. J., Aarnoutse, R. E., Diacon, A. H., Dawson, R., Gillespie, S. H., Boeree, M. J. & Simonsson, U. S. H. Apr 2018 In : Clinical Pharmacology & Therapeutics. 103, p. 674-683 10 p.

    Research output: Research - peer-reviewArticle

  3. Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis

    Fregonese, F. , Ahuja, S. D. , Akkerman, O. W. , Arakaki-Sanchez, D. , Ayakaka, I. , Baghaei, P. , Bang, D. , Bastos, M. , Benedetti, A. , Bonnet, M. , Cattamanchi, A. , Cegielski, P. , Chien, J-Y. , Cox, H. , Dedicoat, M. , Erkens, C. , Escalante, P. , Falzon, D. , Garcia-Prats, A. J. , Gegia, M. & 38 others Gillespie, S. H., Glynn, J. R., Goldberg, S., Griffith, D., Jacobson, K. R., Johnston, J. C., Jones-López, E. C., Khan, A., Koh, W-J., Kritski, A., Lan, Z. Y., Lee, J. H., Li, P. Z., Maciel, E. L., Galliez, R. M., Merle, C. S. C., Munang, M., Narendran, G., Nguyen, V. N., Nunn, A., Ohkado, A., Park, J. S., Phillips, P. P. J., Ponnuraja, C., Reves, R., Romanowski, K., Seung, K., Schaaf, H. S., Skrahina, A., Soolingen, D. V., Tabarsi, P., Trajman, A., Trieu, L., Banurekha, V. V., Viiklepp, P., Wang, J-Y., Yoshiyama, T. & Menzies, D. Apr 2018 In : The Lancet Respiratory Medicine. 6, 4, p. 265-275 11 p.

    Research output: Research - peer-reviewArticle

  4. Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study

    Tweed, C. D., Wills, G. H., Crook, A. M., Dawson, R., Diacon, A. H., Louw, C. E., McHugh, T. D., Mendel, C., Meredith, S., Mohapi, L., Murphy, M. E., Murray, S., Murthy, S., Nunn, A. J., Phillips, P. P. J., Singh, K., Spigelman, M. & Gillespie, S. H. 28 Mar 2018 In : BMC Medicine. 16, 10 p., 46

    Research output: Research - peer-reviewArticle

Related by journal

  1. Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation

    Millard, J., Pertinez, H., Bonnett, L., Model, E. M., Dartois, V., Johnson, J. L., Caws, M., Tiberi, S., Bolhuis, M., Alffenaar, J-W. C., Davies, G. & Sloan, D. J. 23 Mar 2018 In : Journal of Antimicrobial Chemotherapy. Advance Article, 8 p.

    Research output: Research - peer-reviewArticle

  2. Has primary care antimicrobial use really been increasing? Comparison of changes in different prescribing measures for a complete geographic population 1995–2014

    Neilly, M. D. J., Guthrie, B., Hernandez Santiago, V., Vadiveloo, T., Donnan, P. T. & Marwick, C. A. 1 Oct 2017 In : Journal of Antimicrobial Chemotherapy. 72, 10, p. 2921-2930 10 p.

    Research output: Research - peer-reviewArticle

  3. Improved power for TB phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methods

    Svensson, R. J., Gillespie, S. H. & Simonsson, U. S. H. 1 Aug 2017 In : Journal of Antimicrobial Chemotherapy. 72, 8, p. 2311-2319 9 p.

    Research output: Research - peer-reviewArticle

  4. ST3268: a geographically widespread primate MRSA clone

    Hsu, L-Y., Holden, M. T. G., Koh, T. H., Pettigrew, K. A., Cao, D., Hon, P. Y., Sergio, D. M., Pena, E. & Ogden, B. E. 1 Aug 2017 In : Journal of Antimicrobial Chemotherapy. 72, 8, p. 2401-2403 2 p.

    Research output: Research - peer-reviewLetter

  5. Time series analysis of the impact of an intervention in Tayside, Scotland to reduce primary care broad-spectrum antimicrobial use

    Hernandez-Santiago, V., Marwick, C. A., Patton, A., Davey, P. G., Donnan, P. T. & Guthrie, B. 1 Aug 2015 In : Journal of Antimicrobial Chemotherapy. 70, 8, p. 2397-2404 8 p., dkv095

    Research output: Research - peer-reviewArticle

ID: 194099904